Page 933 - Adams and Stashak's Lameness in Horses, 7th Edition

Principles of Therapy for Lameness 899

14. Ferrari G, Cusella‐De Angelis G, Coletta M, et al. Muscle regen- aspirate and their effect on tendon and ligament gene expression.
J Orthop Res 2009. doi:10.1002/jor.20853.
eration by bone marrow‐derived myogenic progenitors. Science 31. McIlwraith C. General pathobiology of the joint and response to
VetBooks.ir 15. Gaughan EM, Nixon AJ, Krook LP, et al. Effects of sodium hyalu- 32. Nixon AJ, Brower‐Toland BD, Bent SJ, et al. Insulinlike growth
(80) 1998. doi:10.1126/science.279.5356.1528.
injury. In McIlwraith C, Trotter G, eds. Joint Disease in the Horse.
ronate on tendon healing and adhesion formation in horses. Am J
Philadelphia, WB Saunders, 1996;40–70.
Vet Res 1991;52:764–773.
16. Geburek F, Lietzau M, Beineke A, et al. Effect of a single injection
Relat Res 2000. doi:10.1097/00003086‐200010001‐00026.
of autologous conditioned serum (ACS) on tendon healing in factor‐I gene therapy applications for cartilage repair. Clin Orthop
equine naturally occurring tendinopathies. Stem Cell Res Ther 33. Nixon AJ, Dahlgren LA, Haupt JL, et al. Effect of adipose‐derived
2015;6:126. doi:10.1186/s13287‐015‐0115‐0. nucleated cell fractions on tendon repair in horses with collagenase‐
17. Geburek F, Gaus M, van Schie HTM, et al. Effect of intralesional induced tendinitis. Am J Vet Res 2008. doi:10.2460/ajvr.69.7.928.
platelet‐rich plasma (PRP) treatment on clinical and ultrasono- 34. Pacini S, Spinabella S, Trombi L, et al. Suspension of bone mar-
graphic parameters in equine naturally occurring superficial digital row–derived undifferentiated mesenchymal stromal cells for
flexor tendinopathies – a randomized prospective controlled clinical repair of superficial digital flexor tendon in race horses. Tissue
trial. BMC Vet Res 2016;12:191. doi:10.1186/s12917‐016‐0826‐1. Eng 2007. doi:10.1089/ten.2007.0108.
18. Geburek F, Mundle K, Conrad S, et al. Tracking of autologous 35. Richardson LE, Dudhia J, Clegg PD, et al. Stem cells in veterinary
adipose tissue‐derived mesenchymal stromal cells with in vivo medicine – attempts at regenerating equine tendon after injury.
magnetic resonance imaging and histology after intralesional Trends Biotechnol 2007. doi:10.1016/j.tibtech.2007.07.009.
treatment of artificial equine tendon lesions—a pilot study. Stem 36. Ross MW, Genovese RL, Dyson SJ, et al. Superficial digital flexor
Cell Res Ther 2016;7:21. doi:10.1186/s13287‐016‐0281‐8. tendonitis. In Diagnosis and Management of Lameness in the
19. Godwin EE, Young NJ, Dudhia J, et al. Implantation of bone mar- Horse, 2nd ed. 2010. doi:10.1016/B978‐1‐4160‐6069‐7.00069‐9.
row‐derived mesenchymal stem cells demonstrates improved out- 37. Russell JW, Russell TM, Vasey JR, et al. Autologous bone marrow
come in horses with overstrain injury of the superficial digital aspirate for treatment of superficial digital flexor tendonitis in
flexor tendon. Equine Vet J 2012;44:25–32. doi:10.1111/ 105 racehorses. Vet Rec 2016;179:69. doi:10.1136/vr.103620.
j.2042‐3306.2011.00363.x. 38. Schnabel LV, Mohammed HO, Jacobson MS, et al. Effects of plate-
20. Goodrich L, Frisbie D, Kisiday J. How to harvest bone marrow let rich plasma and acellular bone marrow on gene expression pat-
derived mesenchymal stem cells for expansion and injection. Proc terns and DNA content of equine suspensory ligament explant
Am Assoc Equine Pract 2008;54:252–257. cultures. Equine Vet J 2008. doi:10.2746/042516408X278030.
21. Harkins J, Mundy G, Stanley S, et al. Lack of local anaesthetic 39. Schnabel LV, Lynch ME, van der Meulen MCH, et al.
efficacy of Sarapin in the abaxial sesamoid block model. J Vet Mesenchymal stem cells and insulin‐like growth factor‐I gene‐
Pharmacol Ther 1997;20:229–232. enhanced mesenchymal stem cells improve structural aspects of
22. Hildebrand KA, Jia F, Woo SLY. Response of donor and recipient healing in equine flexor digitorum superficialis tendons. J
cells after transplantation of cells to the ligament and tendon. Orthop Res 2009;27:1392–1398. doi:10.1002/jor.20887.
Microsc Res Tech 2002. doi:10.1002/jemt.10114. 40. Seabaugh KA, Thoresen M, Giguère S. Extracorporeal shock-
23. Hix J, Klaassen M, Foreman R, et al. An autologous anti‐inflam- wave therapy increases growth factor release from equine plate-
matory protein solution yielded a favorable safety profile and sig- let‐rich plasma in vitro. Front Vet Sci 2017;4:205. doi:10.3389/
nificant pain relief in an open‐label pilot study of patients with fvets.2017.00205.
osteoarthritis. Biores Open Access 2017;6:151–158. doi:10.1089/ 41. Smith RKW. Mesenchymal stem cell therapy for equine tendinop-
biores.2017.0027. athy. Disabil Rehabil 2008. doi:10.1080/09638280701788241.
24. Hraha TH, Doremus KM, McIlwraith CW, et al. Autologous con- 42. Smith JJ, Ross MW, Smith RKW. Anabolic effects of acellular
ditioned serum: the comparative cytokine profiles of two com- bone marrow, platelet rich plasma, and serum on equine suspen-
mercial methods (IRAP and IRAP II) using equine blood. Equine sory ligament fibroblasts in vitro. Vet Comp Orthop Traumatol
Vet J 2011;43:516–521. doi:10.1111/j.2042‐3306.2010.00321.x. 2006;19:43–47.
25. Hu AJ, Bramlage LR. Racing performance of Thoroughbreds with 43. Ursini TL, Amelse LL, Elkhenany HA, et al. Retrospective analysis
superficial digital flexor tendonitis treated with desmotomy of the of local injection site adverse reactions associated with 230 allo-
accessory ligament of the superficial digital flexor tendon: 332 genic administrations of bone marrow‐derived mesenchymal stem
cases (1989–2003). J Am Vet Med Assoc 2014;244:1441–1448. cells in 164 horses. Equine Vet J 2018. doi:10.1111/evj.12992.
doi:10.2460/javma.244.12.1441. 44. Waselau M, Sutter WW, Genovese RL, et al. Intralesional injection
26. Kraus KH, Kirker‐Head C. Mesenchymal stem cells and bone regen- of platelet‐rich plasma followed by controlled exercise for treatment
eration. Vet Surg 2006. doi:10.1111/j.1532‐950X.2006.00142.x. of midbody suspensory ligament desmitis in Standardbred race-
27. Madison JB. Acute and chronic tendinitis in horses. Compend horses. J Am Vet Med Assoc 2008. doi:10.2460/javma.232.10.1515.
Contin Educ Pract Vet 1995;17:853–856. 45. Witte S, Dedman C, Harriss F, et al. Comparison of treatment
28. Marr CM, Love S, Boyd JS, et al. Factors affecting the clinical outcomes for superficial digital flexor tendonitis in National
outcome of injuries to the superficial digital flexor tendon in Hunt racehorses. Vet J 2016;216:157–163. doi:10.1016/J.
National Hunt and point‐to‐point racehorses. Vet Rec 1993. TVJL.2016.08.003.
doi:10.1136/vr.132.19.476. 46. Yamamoto E, Hata D, Kobayashi A, et al. Effect of beta‐amino-
29. Marxen S, Lacerda Neto JC, Canola JC, et al. Intralesional poly- proprionitrile and hyaluronic acid on repair of collagenase‐
sulphated glycosaminoglycan as treatment of equine collagenase induced injury of the rabbit Achilles tendon. J Comp Pathol
induced tendinitis: clinical, ultrasonographic and histopathologic 2002;126:161–170.
evaluation. 56, 2004. http://www.scielo.br/pdf/abmvz/v56n6/ 47. Zhang J, Keenan C, Wang JH‐C. The effects of dexamethasone on
a02v56n6.pdf. Accessed October 9, 2018. human patellar tendon stem cells: implications for dexametha-
30. McCarrel T, Fortier L. Temporal growth factor release from plate- sone treatment of tendon injury. J Orthop Res 2013;31:105–110.
let‐rich plasma, trehalose lyophilized platelets, and bone marrow doi:10.1002/jor.22193.